CEP164
protein-codingcentrosomal protein 164
Gene summary
This gene encodes a centrosomal protein involved in microtubule organization, DNA damage response, and chromosome segregation. The encoded protein is required for assembly of primary cilia and localizes to mature centrioles. Defects in this gene are a cause of nephronophthisis-related ciliopathies. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~98.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0017842
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013917
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0700344
Submitter: ClinGen
The first report of ciliopathy-*CEP164* was in 2012 by Chaki M et al. (PMID: 22863007). Individuals with ciliopathy-*CEP164* present with a broad range of phenotypes, including various combinations of nephronophthisis, respiratory system impact, retinal degeneration, developmental delay, CNS malformations, polydactyly, bronchiectasis and obesity. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism and inheritance pattern. The spectrum of reported phenotypes encompassed various signs and symptoms associated with defects of both the primary and motile cilium, in line with the known roles of *CEP164*. Therefore, the following disease entities have been lumped into one disease entity: nephronophthisis 15 (MONDO:0013917) and Senior-Loken syndrome (MONDO:0017842). Seven different variants (2 missense, 3 nonsense, 1 frameshift and 1 stop loss) that have been reported in 6 probands in 4 publications (PMIDs: 22863007, 34132027, 27708425, 36273371) are included in this curation. The mechanism of pathogenicity is reported to be loss-of-function. Genetic variants have been associated with reduced protein interactions, ciliary defects and DNA damage. This gene-disease association is also supported by expression studies, multiple animal models (zebrafish and mouse) as well as in vitro functional assays (PMIDs: 31990917, 22863007, 23150559, 29244804, 31248650). Ablation of cep164 protein in foxj1-positive mice tissues resulted in loss of airway multicilia and hydrocephalus, indicating its essential roles in airway multiciliated cell differentiation. A similar effect was also detected in ependymal cells, seminiferous tubules, and oviducts of the knockout mice (PMID: 29244804). The Zebrafish cep164 knockout model could recapitulate various aspects of the ciliopathy-disease spectrum, exhibiting ventral body axis curvature, laterality defects, hydrocephalus, kidney cysts, and retinal dysplasia (PMID: 22863007). One nonsense variant (p.Gln525Ter/p.Gln525Ter) has been associated with a dominant negative effect on cell growth (PMID: 22863007). The proband had bronchiectasis along with nephronophthisis and retinal affection. Devlin LA et al. investigated the motile ciliopathy affection in a compound heterozygous patient carrying the aforementioned variant and a stop gain in the penultimate exon (NM_014956.5 c.4228C > T p.(Gln1410Ter) (PMID:36273371). The male fertile patient had a predominantly respiratory phenotype (bronchiectasis, recurrent lower respiratory tract infection, recurrent ear infection and low nasal nitric oxide) and loss of *CEP164* in the centriolar region in his nasal brushing (NB) and ALI‐cultured cells. High‐speed video microscopy of the patient's NB epithelium detected uncoordinated cilia with reduced ciliary beat amplitude, and lack of mucociliary clearance. In summary, *CEP164* is definitively associated with autosomal recessive ciliopathy-*CEP164*. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Kidney Cystic and Ciliopathy Disorders GCEP on 10/27/21 (SOP Version 8).
Inheritance Pattern: AR
Disease ID:MONDO:0013917
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0013917
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0013917
Submitter: Laboratory for Molecular Medicine
This gene-disease relationship has undergone rapid assessment. Classifications are based on preliminary review of gene-disease validity during analysis of genomic sequencing results.
Clinical Genomic Database (CGD)
Manifestation: Gastrointestinal; Neurologic; Ophthalmologic; Pulmonary; Renal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CEP164 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_014956.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 9 | 403 | 1 | 413 | ||
| missense | 1 | 2 | 790 | 46 | 4 | 843 |
| nonsense | 20 | 28 | 3 | 51 | ||
| start loss | 0 | |||||
| frameshift | 29 | 37 | 5 | 71 | ||
| splice donor/acceptor (+/-2bp) | 1 | 40 | 15 | 1 | 57 | |
| Total | 51 | 107 | 822 | 450 | 5 | 1435 |
Highest pathogenic variant AF is 0.000080654565
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055771.4 | 31 | MANE Select | |
| Ensembl | ENSP00000278935.3 | 31 | MANE Select | |
| RefSeq | NP_001258862.1 | 31 | Standard | |
| RefSeq | NP_001427878.1 | 31 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| cep164 | Danio rerio | Structure: pronephric tubule Quality: cystic abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Regulation of PLK1 Activity at G2/M Transition
- Recruitment of mitotic centrosome proteins and complexes
- Loss of Nlp from mitotic centrosomes
- Loss of proteins required for interphase microtubule organization from the centrosome
- Centrosome maturation
Biological Process
- G2/M transition of mitotic cell cycle
- DNA repair
- regulation of G2/M transition of mitotic cell cycle
- cell division
- cilium assembly
Molecular Function
- protein binding
Cellular Component
- extracellular space
- nucleoplasm
- cytoplasm
- centrosome
- centriole
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000278935
- Coding exons
- 31
- Length
- 98712
- Individuals with no LoFs
- 125273
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 475
- Defined
- 125748
- p
- 0.00189
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.345 | 779 | 807 | 0.966 | 0.0000460 | 9488 |
| Missense (PolyPhen) | 175 | 202.28 | 0.86515 | 2693 | ||
| Synonymous | -1.33 | 346 | 316 | 1.09 | 0.0000174 | 2829 |
| Loss of Function | 2.78 | 55 | 82.2 | 0.669 | 0.00000434 | 934 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0020 | 0.0020 | notable |
| Latino/Admixed American | 0.0011 | 0.0011 | notable |
| Ashkenazi Jewish | 0.00030 | 0.00030 | rare |
| East Asian | 0.00044 | 0.00044 | rare |
| Finnish | 0.0070 | 0.0065 | notable |
| European (Non-Finnish) | 0.0020 | 0.0020 | notable |
| South Asian | 0.00056 | 0.00056 | rare |
| Other | 0.0018 | 0.0018 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Plays a role in microtubule organization and/or maintenance for the formation of primary cilia (PC), a microtubule-based structure that protrudes from the surface of epithelial cells. Plays a critical role in G2/M checkpoint and nuclear divisions. A key player in the DNA damage-activated ATR/ATM signaling cascade since it is required for the proper phosphorylation of H2AX, RPA, CHEK2 and CHEK1. Plays a critical role in chromosome segregation, acting as a mediator required for the maintenance of genomic stability through modulation of MDC1, RPA and CHEK1. {ECO:0000269|PubMed:17954613, ECO:0000269|PubMed:18283122, ECO:0000269|PubMed:23348840}.;
- Disease
- DISEASE: Nephronophthisis 15 (NPHP15) [MIM:614845]: An autosomal recessive disorder characterized by the association of nephronophthisis with Leber congenital amaurosis and retinal degeneration, often resulting in blindness during childhood. Additional features include seizures, cerebellar vermis hypoplasia, facial dysmorphism, bronchiectasis and liver failure. Nephronophthisis is a chronic tubulo-interstitial nephritis that progresses to end-stage renal failure. {ECO:0000269|PubMed:22863007}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- LoFtool
- 0.884
- RVIS EVS
- 0.09
- RVIS percentile EVS
- 60.33
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.811
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |